SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
K. Bahl, E.S. Yang, C. Henry, K.M. Morabito et autres
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have led to the development of mutations that stabilize Betacoronavirus spike proteins in the prefusion state, improving their expression …
in, us (code pays fourni par la source)